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ARTICLE
Multivalent interactions drive nucleosome binding
and efficient chromatin deacetylation by SIRT6
Wallace H. Liu1,2, Jie Zheng3, Jessica L. Feldman4, Mark A. Klein 1,2, Vyacheslav I. Kuznetsov1,2,
Craig L. Peterson4, Patrick R. Griffin 3 & John M. Denu 1,2✉
The protein deacetylase SIRT6 maintains cellular homeostasis through multiple pathways
that include the deacetylation of histone H3 and repression of transcription. Prior work
suggests that SIRT6 is associated with chromatin and can substantially reduce global levels of
H3 acetylation, but how SIRT6 is able to accomplish this feat is unknown. Here, we describe
an exquisitely tight interaction between SIRT6 and nucleosome core particles, in which a 2:1
enzyme:nucleosome complex assembles via asymmetric binding with distinct affinities. While
both SIRT6 molecules associate with the acidic patch on the nucleosome, we find that the
intrinsically disordered SIRT6 C-terminus promotes binding at the higher affinity site through
recognition of nucleosomal DNA. Together, multivalent interactions couple productive
binding to efficient deacetylation of histones on endogenous chromatin. Unique among
histone deacetylases, SIRT6 possesses the intrinsic capacity to tightly interact with nucleo-
somes for efficient activity.
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Recent animal studies reveal that the NAD
+-dependent
deacylase SIRT6 promotes longevity, attributed to
homeostatic roles in multiple pathways1,2. SIRT6 knockout
mice die several weeks after experiencing hypoglycemia, osteo-
penia, and lymphopenia, while SIRT6-deficient monkeys only live
several hours after birth, experiencing similar defects3,4. Over-
expression of SIRT6 or SIRT6 isoforms with higher activity lead
to longevity phenotypes in various rodent models5,6. Function-
ally, SIRT6 removes specific fatty acyl groups from substrates,
most notably acetyl modifications from histone H37–9. Histone
deacetylation drives repression of a host of glycolytic genes and
oncogenic c-myc and NF-ΚB10,11. In addition to deacylation
activity, SIRT6 promotes DNA repair pathways through ADP-
ribosylation of PARP-1, as well as recruitment of the chromatin
remodellers SNF2H and CHD412–14. Thus, functional SIRT6
attends to the upkeep of myriad pathways that maintain meta-
bolism and tumor suppression.
The collective biological insight into SIRT6 function reveals that
enzyme activity is linked to cellular homeostasis. Multiple studies
show, however, that SIRT6 deacetylates lysine 9 on histone H3
(H3K9ac) peptides with a turnover rate on the minutes scale, ~3
orders of magnitude slower than other sirtuins8,15. This poor
in vitro activity does not reconcile with observations in biology,
suggesting that peptide-independent mechanisms promote more
robust SIRT6 activity. Importantly, histone peptides only repre-
sent a potentially small portion of the interaction surface present
on nucleosomes, the fundamental repeating unit of chromatin
structure. Nucleosome particles consist of a tetrameric unit of
histones (H3/H4)2 flanked by two H2A/H2B dimers, forming an
octameric core that is enveloped by ~147 base pairs of superhelical
DNA16. Proteins bind nucleosomes through various docking sites,
including acidic patches presented by each of the H2A/H2B
dimers and DNA regions of various curvatures17. Although many
histone deacetylases are members of multi-subunit complexes that
possess separate nucleosome-binding proteins18, SIRT6 is not
known to be part of such complexes. Instead, SIRT6 has been
observed to directly bind heterogenous nucleosomes in vitro, and
is found almost exclusively in the chromatin sub-fraction of the
nucleus3,19. Importantly, SIRT6 alone incubated with recon-
stituted nucleosomes leads to faster H3K9ac deacetylation than
parallel experiments with histones alone20, suggesting that SIRT6
might intrinsically bind nucleosomes with high affinity. Thus, we
reason that tight, specific SIRT6-nucleosome interactions promote
improved enzyme efficacy that endows SIRT6 with the capacity to
globally reduce H3 acetylation.
Surprisingly, a rigorous biochemical and thermodynamic
understanding of the mechanisms driving SIRT6 interactions with
nucleosomes is lacking. To uncover the underlying principles that
lead to assembly of a SIRT6:nucleosome complex, and how this
binding is coupled to efficient histone deacetylation, we investigate
the complex with biophysical and biochemical tools. We show that
SIRT6 associates with nucleosomes through two asymmetric
binding sites using multiple contact points, including an intrin-
sically disordered C-terminus that associates with nucleosomal
DNA. Together, these multivalent interactions promote high
affinity engagement with substrate, leading to productive deace-
tylation in cells. Unlike most histone deacetylases and acetyl-
transferases that require multi-subunit complexes, our studies
reveal that SIRT6 harbors the intrinsic capacity to bind tightly and
efficiently catalyze the removal of acetyl-groups from nucleosomes
without the need to form elaborate protein complexes.
Results
Two SIRT6 molecules engage a nucleosome core particle.
SIRT6 activity appears more robust when endogenously-sourced
nucleosomes, rather than histone peptides, are used as sub-
strates20. This suggests that direct binding between SIRT6 and
nucleosomes is thermodynamically more favorable than interac-
tions with histones and histone peptides, explaining the apparent
faster rates of deacetylation. To quantitatively assess the strength
of nucleosome binding, we analyzed the complexes formed in
electrophoretic mobility shift assays (EMSAs) when purified
SIRT6 was added to recombinant 601-positioned nucleosome
core particles (NCPs; Fig. 1a and Supplementary Fig. 1a)21.
Notably, two distinct, bound complexes were evident as SIRT6
was titrated into a fixed level of NCPs: the lower bound complex
(faster migrating) appeared and saturated at much lower SIRT6
concentrations, while the slower migrating species appeared at
higher concentrations of SIRT6 (Fig. 1a). To determine apparent
binding affinity, we used both shifted complexes together as the
bound fraction, and the free NCP band as the unbound fraction.
The composite affinity is exceptionally tight (KD(app)= 13 nM;
Fig. 1a and Table 1), enabling the complex to remain fully bound
even in the presence of high ionic strength (Supplementary
Fig. 2a). Importantly, the low nanomolar affinity observed for
NCPs is unprecedented for deacetylases, indicative of novel
binding modes exclusive to SIRT6.
The observation of two separate complexes formed between
SIRT6 and NCPs suggested possible assembly into a final 2:1
SIRT6:nucleosome configuration, or that two 1:1 complexes with
distinct conformations can form. To differentiate between these
possibilities, we labeled SIRT6 with tetramethylrhodamine
(TAMRA) at cysteine 320 (SIRT6(TAMRA)) and performed
nucleosome-binding experiments (Fig. 1b). After scanning the
TAMRA signal, we also imaged SYBR Safe-stained DNA and
immunoblotted histone H3. The merged fluorescent image
showed that the slowest migrating complex indeed has twice
the TAMRA signal of the faster complex, providing evidence that
two SIRT6 molecules occupy a single, intact nucleosome (Fig. 1b
and Supplementary Fig. 2b).
The 2:1 complex might be formed through nucleosome
bridging, or the individual SIRT6 molecules might dimerize prior
to nucleosome encounter. To determine if dimerization is a
possible mechanism, we monitored the oligomerization of SIRT6
through fluorescence anisotropy. We prepared SIRT6 labeled
with pyrene at cysteine 18 (SIRT6(Py)), then measured pyrene
anisotropy with titration of unlabeled SIRT6 (Fig. 1c). The
resulting isotherm showed that SIRT6 indeed increased the
anisotropy signal, but with an oligomerization constant 1000x
weaker than the affinity of SIRT6:NCP (Fig. 1a and Table 1).
Thus, SIRT6 is unlikely to oligomerize before binding nucleo-
somes, consistent with the EMSA results, as a dimerization
mechanism would not produce a 1:1 SIRT6:NCP complex in
native gels (Fig. 1a). Together, assembly of a high affinity 2:1
SIRT6:NCP complex requires two binding sites bridged by the
nucleosome.
The appearance of a 1:1 complex in the SIRT6 titration of
NCPs suggested that the two binding events likely involve a high
affinity site and a low affinity one (Fig. 1d). To confirm this
equilibrium model and measure the individual binding constants
in solution, we designed a more sensitive FRET assay. We
reconstituted nucleosomes with Cy3 positioned at the first
nucleotide of the DNA entry/exit site, and prepared SIRT6
labeled with Tide Quencher 3 (TQ3) at cysteine 18 (SIRT6(TQ3)),
providing the enzyme with a dark acceptor fluorophore for Cy3
emission (Fig. 1e and Supplementary Fig. 2c–f). The Förster
radius of the Cy3-TQ3 FRET pair was calculated to be 38.1 Å
(Methods section). Upon titrating SIRT6(TQ3) to Cy3-labeled
NCPs, we observed maximum FRET efficiency at 57%, which
corresponded to an average distance of ~36 Å between the labeled
cysteines and the Cy3-labeled nucleotide. The binding isotherm
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Fig. 1 SIRT6 and NCPs assemble with low nanomolar affinity via a two-site binding mechanism. a EMSA of NCPs bound to varying SIRT6
concentrations, then detected by SYBR Safe fluorescence. Data are presented as the mean ± s.d. from six independent experiments. The apparent KD was
calculated using a ligand-depleted equation. b SIRT6:NCP stoichiometry was determined by detecting fluorescence from both SYBR Safe-stained DNA and
TAMRA-labeled SIRT6. The white numbers indicate the relative TAMRA signal in the higher shifted band compared to the lower bound band, both
normalized to DNA content. The gel was subsequently blotted for histone H3. The image is representative of three independent experiments. c To measure
SIRT6 self-oligomerization, the fluorescence anisotropy of pyrene-labeled SIRT6 was monitored with titration of unlabeled SIRT6. Data are presented as
mean ± s.d. from three independent experiments. d The data indicates a two-site binding mechanism, in which two SIRT6 molecules bind at separate sites
on a nucleosome. e A FRET assay was employed to measure binding between 1 nM of Cy3-labeled nucleosomes and SIRT6 labeled with TQ3, which
accepts energy transfer from Cy3. The titration reveals a two-site binding curve (Supplementary Fig. 2f). The intermediate binding constant KD(High) was
fitted to a ligand-depleted equation from titration points up to 5 nM SIRT6(TQ3), while KD(Low) was fitted to a specific-binding equation from data points
ranging from 5 nM to 500 nM. Data are presented as mean ± s.d. from four independent experiments. Source data are provided as a source data file.
Table 1 KD and IC50 values determined in this study.
Protein or complex Binding partner EMSA KD or IC50 (M) Fluorescence KD (M)
NCP SIRT6 1.3 ± 0.2 × 10−8 –
NCP(Cy3) SIRT6(TQ3) – KD(High) 4.6 ± 0.3 × 10−10
KD(Low) 3.0 ± 0.9 × 10−8
NCP(AP) SIRT6 1.4 ± 0.2 × 10−7 –
NCP SIRT6+ SIRT6(1–292) KD(Low) 4.0 ± 1.4 × 10−8 –
NCP SIRT6(AAA) 9.7 ± 0.6 × 10−8 –
NCP SIRT6(1–292) 2.5 ± 0.1 ×10−7 –
NCP SIRT6(1–301) 1.4 ± 0.1 × 10−7 –
NCP SIRT6(270–355) 4.0 ± 0.1 × 10−7 –
DNA SIRT6(270–355) 4.5 ± 0.1 × 10−7 –
NCP:SIRT6 LANA 9.5 ± 4.5 × 10−6 –
NCP:SIRT6(1–292) LANA 6.1 ± 2.1 × 10−6 –
NCP:SIRT6(270–355) LANA n.i. –
SIRT6(Py) SIRT6 – 1.4 ± 0.6 × 10−5
n.i. no inhibition.
KD and IC50 values for each interaction studied (at least three independent experiments) were calculated as described in the Methods section. Curve-fitting errors are reported for each value.
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revealed a two-step curve, in which the first site plateaued before
25% FRET efficiency (KD(High)= 0.5 nM), while the second site
displayed weaker affinity (KD(Low)= 30 nM; Fig. 1e, Supplemen-
tary Fig. 2f, and Table 1). Thus, the two SIRT6 binding sites on a
nucleosome are asymmetric, which suggests that two separate
mechanisms of binding occur to form a tight complex.
Identification of interacting regions on SIRT6 and NCPs. To
map the binding regions and provide residue-level insight into
how SIRT6 associates with nucleosomes, we employed a method
that incorporates hydrogen-deuterium exchange (HDX) coupled
to mass spectrometry22. The SIRT6:NCP complex, or the indi-
vidual SIRT6 and nucleosome constituents, were analyzed by
differential HDX to determine regions that are perturbed in the
complex. Peptides that exhibit more protection from HDX in the
complex might indicate sites of protein–protein interactions,
while those that display more exchange may represent regions of
increased structural plasticity. The results showed significant
HDX changes in both SIRT6 and NCPs indicative of specific
binding regions or conformational changes.
Nucleosomes that were bound to SIRT6 experienced more
exchange in the H4 C-terminus (residues 87–102), indicating a
possible structural destabilization induced by SIRT6 (Supple-
mentary Fig. 3a). The H4 C-terminus is known to be structurally
plastic, as recent studies of SNF2H- and HP1-bound NCPs
revealed that this octamer region can experience increased solvent
exposure due to protein binding23,24. Importantly, the H4
residues are buried in the canonical nucleosome structure16,
which suggests that SIRT6 interactions with other histone
domains or nucleosomal DNA perturb the NCP structure.
One particular structural feature frequently utilized by
nucleosome-interacting partners is an H2A/H2B acidic patch,
which is located on either side of the NCP disc-like structure
(Fig. 2a)17,25. To test SIRT6 binding to the acidic patch, we
reconstituted nucleosomes bearing four alanine mutations on
acidic H2A residues at the patch (NCP(AP); E61, E64, D90, E92).
In EMSA experiments, SIRT6 exhibited weaker binding to
NCP(AP) than to wild-type nucleosomes (KD(app)= 138 nM,
Fig. 2a and Supplementary Fig. 3b). Importantly, the bound
species observed were slower migrating complexes, in contrast to
the specific 1:1 and 2:1 SIRT6:NCP complexes previously
observed (Fig. 1a). To further probe SIRT6 binding to the acidic
patch, we used the Latency Associated Nuclear Antigen (LANA)
peptide from Kaposi’s sarcoma-associated herpesvirus as a
competitor of SIRT6:NCP interactions in EMSAs25. LANA
clearly disrupted the 2:1 SIRT6:NCP complex into a 1:1 complex
at the lowest LANA concentration tested (300 nM), and
abrogated all binding at 100 µM peptide concentration (IC50=
9.5 µM; Fig. 2b and Supplementary Fig. 3b). Together, these data
are consistent with both SIRT6 molecules utilizing the nucleo-
somal acidic patch. The two SIRT6 proteins likely each occupy a
separate acidic patch, given that SIRT6 remains monomeric
under the concentrations used, and the acidic patch is not a large
interface known to bind multiple proteins simultaneously17.
If LANA displaces SIRT6 from nucleosomes, then one would
predict that this peptide might disrupt SIRT6 activity on
nucleosomes. To assess nucleosome deacetylation, we utilized
native chromatin from HCT116 cells as substrate. Cells were
treated with trichostatin A to preserve acetylation levels before
lysis, then digested with micrococcal nuclease A (MNase A) to
generate mono- and poly-nucleosomes. In the presence of LANA
peptide, SIRT6 activity on HCT116 nucleosomes was decreased
compared to control reactions without peptide (Supplementary
Fig. 3c). Thus, binding through the acidic patch supports SIRT6
function on nucleosomes.
On the SIRT6 structure, nucleosome binding increased
hydrogen-deuterium exchange at the N-terminal loop (Fig. 2c;
residues 8–29). Mutations of candidate charged residues in this
loop did not change the affinity for nucleosome binding
(Supplementary Fig. 1d). Thus, this N-terminal loop does not
appear to contribute binding energy. Within nearby structural
regions, we observed protection from exchange in the N-terminal
helix, as well as in peptides corresponding to residues 101–108
and 202–209. Notably, all residues that experienced significant
protection cluster to a common interface that is adjacent to the C-
terminus and distant from the active site (Fig. 2c). Given the
significant HDX changes in this interface, we hypothesized that it
represents a nucleosome-binding region (NBR).
To determine if the N-terminal helix (residues 28–43) in the
NBR participates in NCP interactions, we employed an antibody
raised against SIRT6 residues 19–33 (Fig. 2d). SIRT6 can form a
1:1 complex exclusively in native gels at 30 nM protein
concentration, or form both 1:1 and 2:1 SIRT6:NCP complexes
at 100 nM SIRT6 (Fig. 2d; lanes 2 and 4). Thus, the antibody was
allowed to associate with SIRT6 before NCP binding. The
complexes were then monitored in EMSAs, where disassembly or
supershifting might occur, depending on whether the epitope was
essential or excluded in SIRT6:NCP binding, respectively. The
results showed that the antibody fully disrupted assembly of both
the 1:1 and 2:1 SIRT6:NCP complexes (lanes 3 and 5). Thus, these
data support the N-terminal helix engaging with both the high-
and low-affinity binding sites on NCPs.
In addition to antibody competition, we introduced strategic
amino acid mutations in SIRT6. A set of mutations made within
the N-terminal helix (34A/35A/37A) was not bacterially
expressed, while those that included amino acids 101–108
completely eliminated enzyme activity (Supplementary Fig. 1c),
making these mutants unsuitable for validation. Simultaneous
alanine substitutions at three SIRT6 residues, however, retained
protein structure and function (S45, N206, and N208 (SIRT6
(AAA)); Supplementary Fig. 1a–c). S45 was not represented among
peptides identified from HDX analysis, but is positioned in a loop
immediately following the N-terminal helix, in close proximity to
the loop occupied by N206 and N208 (Fig. 2e). SIRT6(AAA)
displayed a 7-fold weaker KD for NCPs in EMSAs (KD(app)= 96.6
nM; Fig. 2e and Table 1). The moderate change in affinity
suggests that the HDX changes in the NBR loops represent either
an indirect structural change, or a weak binding contribution that
does not supply direct hydrogen bonding.
If the mutations in SIRT6(AAA) are distant from the active site
and partially impair nucleosome binding, then we predicted the
mutant to retain full activity on peptide substrate while
deacetylating nucleosomes with lower efficiency. Wild-type and
SIRT6(AAA) proteins exhibited similar rates of deacetylation on
H3K9ac peptide, as predicted (Supplementary Fig. 1c). When
provided with native HCT116 nucleosomes as substrate, however,
SIRT6(AAA) deacetylated H3K9ac at a slower rate compared with
wild-type SIRT6 (Supplementary Fig. 3d). Therefore, direct and
high affinity binding to nucleosomes, mediated in part by NBR
residues S45, N206, and N208, is a requirement for efficient
deacetylation.
The CTD of SIRT6 is required for high-affinity binding. The
HDX results suggested that a specific SIRT6 interface associates
with nucleosomes, yet the enzyme engages through asymmetric
binding modes, utilizing two sites with different affinities. This
implies that a separate SIRT6 domain contributes to the favorable
binding energetics at the high affinity site. Residues at the dis-
ordered, highly basic C-terminal domain (CTD), which spans the
final 83 amino acids and shares little sequence identity with other
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nuclear sirtuins, were not represented in any peptide identified in
HDX analysis (Figs. 2c and 3a and Supplementary Fig. 4a). Thus,
we introduced truncations of varying lengths at the C-terminus
and evaluated these variants for nucleosome binding (Fig. 3b).
The C-terminal deletion mutants exclusively formed 2:1 SIRT6:
NCP complexes in the native gel without a detectable 1:1 inter-
mediate, suggesting that the high affinity site was compromised,
which led to a similar affinity for both binding events. As a result,
the overall KD of SIRT6(1–292) and SIRT6(1–301) (KD= 254 and
139 nM, respectively) to nucleosomes is an order of magnitude
weaker than full-length SIRT6 (Fig. 3c, Supplementary Fig. 4b,
and Table 1). Thus, the C-terminally truncated mutants display
impaired binding to NCPs, as well as a loss of the asymmetric
binding mechanism.
Given these changes in binding with the SIRT6(1–292) and
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Fig. 2 SIRT6 and nucleosomes interact through specific regions. a Surface depiction of the nucleosome (3lz0.pdb64) with electrostatics generated by the
APBS plugin for PyMOL65,66. One acidic patch on one side of the NCP is indicated. NCPs assembled with four alanine mutations at the acidic patch
(NCP(AP)) exhibited weaker binding to SIRT6. The image is representative of three independent experiments. b In the LANA peptide competition EMSA,
SIRT6:NCP complexes were prepared with 100 nM SIRT6 and 50mM NCP, then competed with LANA peptide. The image is representative of three
independent experiments. c HDX-MS analysis of differential peptide exchange in the SIRT6:nucleosome interaction. SIRT6 residues that are protected
against exchange when bound to NCPs are highlighted in green and purple colors in the primary sequence, and in purple in the structure of SIRT6 (3pkj.
pdb8). NAD+ (nicotinamide adenine dinucleotide) is included to indicate the active site. d An antibody that recognizes SIRT6 amino acids 19–33 (red
dashed line) was used to probe SIRT6 binding to NCPs. When pre-bound to SIRT6, the antibody disrupts formation of both the 1:1 and 2:1 SIRT6:
nucleosome complexes. The image is representative of three independent experiments. e The zoomed image displays amino acids mutated to alanine
(SIRT6(AAA)) for native gel analysis. The residues occupy loops that reside around a specific interface. On the right, EMSA of SIRT6(AAA) binding to
nucleosomes shows a weakened binding affinity. Data are presented as mean ± s.d. from four independent experiments. Source data are provided as a
source data file.
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utilized at the high affinity site. Under this model, binding to the
lower affinity site (KD(Low)) would be similar between SIRT6 and
SIRT6(1–292). To test this mechanism, we first saturated the high
affinity site on NCPs with 10 nM full-length SIRT6, then added
increasing concentrations of SIRT6(1–292) and subjected the
resulting complexes to native gel analysis (Fig. 3d and Table 1).
The data revealed a dissociation constant (40 nM) similar to the
KD(Low) value reported by the FRET experiment (Fig. 1e),
supporting a model in which the CTD contributes to only the
higher affinity binding event.
To further interrogate this mechanism, we used an antibody
raised against SIRT6 C-terminal residues 330–348 as a probe in
EMSA experiments. The antibody was allowed to bind full-length
SIRT6 before nucleosome addition (Supplementary Fig. 4c).
When only the 1:1 SIRT6:NCP complex is apparent at 20 nM
SIRT6, the antibody fully disrupted this complex (lanes 3 and 4).
When both the 1:1 and 2:1 complexes appeared at 100 nM SIRT6,
the antibody displaced part of the bound population while
supershifting the rest (lanes 5 and 6). Finally, when both binding
sites were saturated, only supershifting occurred, likely due to
CTD-independent interactions driving binding at higher SIRT6
concentrations (lanes 8 and 9). Collectively, the results are
consistent with the observation that the CTD is not necessary for
complete SIRT6:NCP assembly (Fig. 3b), yet is essential for tight
and multivalent binding at a single, high affinity site.
The CTD is an intrinsically disordered DNA-binding domain.
The CTD establishes tighter binding on NCPs, suggesting that this
unique domain recognizes additional structural feature(s) on the
nucleosome. To test if it is necessary to bind the acidic patch, we
used the LANA peptide to measure inhibition of SIRT6(1–292):NCP
binding (Supplementary Fig. 5a). The LANA peptide displaced the
interaction between SIRT6(1–292) and NCPs with a similar IC50 (6.1
µM) as observed for the full-length SIRT6:NCP complex (Supple-
mentary Fig. 3b and Table 1), indicating that the folded core binds
the acidic patch while the CTD engages other parts of the
nucleosome. Given the presence of many basic residues along the
CTD (pI= 10.4) and the propensity of proline-rich domains to
function as DNA-binding regions26,27 (Supplementary Fig. 4a), we
investigated several SIRT6 C-terminal deletion mutants for DNA
binding. In EMSA experiments using 500 nM protein incubated
with the 601-positioning DNA sequence, full-length SIRT6 dis-
played highest affinity for DNA, while the mutants bound notice-
ably weaker (Fig. 4a). In addition, the NBR mutant SIRT6(AAA)
fully bound DNA under the same conditions, consistent with the
folded core and the CTD of SIRT6 having distinct binding contacts
(Supplementary Fig. 5b).
To confirm that the CTD directly interacts with DNA, we
expressed and purified the isolated domain (residues 270–355)
and evaluated DNA binding capacity (Supplementary Fig. 1a).
The domain has no known ordered structure: the only CTD
residues observed in the SIRT6 crystal structure, 272–296, form a
disordered loop8, while bioinformatic predictions indicate that
the entire domain is intrinsically disordered (Fig. 3a). To confirm
these predictions, we determined the 1H NMR spectrum of the
CTD and observed peak clustering at ~7.0–8.5 ppm, which is
characteristic of intrinsically disordered domains (Fig. 4b). In
EMSA experiments, we found that the CTD bound random
sequences of DNA in a commercial 10 base pair ladder, as well as
the 601-positioning sequence (Fig. 4c and Supplementary Fig. 5c).
More strikingly, binding to the latter sequence with and without
the histone octamer assembled on it produced exact binding
isotherms. This reveals that the CTD is not only indiscriminate of
DNA sequences, but recognizes both linear DNA as well as the





























































































































KD(Low) = 40 nM
Fig. 3 The C-terminus of SIRT6 stabilizes the high-affinity binding site. a Schematic of known SIRT6 domains accompanied with a bioinformatic
prediction of protein disorder (MetaPrDos) below. The C-terminal domain (CTD) starts at residue 272 and is predicted to be unstructured. b EMSA
comparison of NCP binding between 100 nM SIRT6 and 500 nM C-terminally truncated SIRT6 variants. The 1:1 SIRT6:nucleosome complex is undetectable
in native gels when the CTD is truncated, even at lower protein concentrations (Supplementary Fig. 4b). The image is representative of three independent
experiments. c As a result, SIRT6(1–292) and SIRT6(1–301) associates with nucleosomes with an order of magnitude weaker affinity. The KDs were calculated
with a ligand-depleted equation from titration of SIRT6(1–292) or SIRT6(1–301) to 50 nM NCP. Data are presented as mean ± s.d. from three independent
experiments. d The weaker binding site on nucleosomes (KD(Low)) does not require the CTD. The high affinity site on nucleosomes was saturated with 10
nM SIRT6, then increasing concentrations of SIRT6(1–292) was added to bind the available site. Although the formation of the fully formed 2:1 complex is
still apparent, it migrates too close to the 1:1 band to accurately quantify. Thus, fraction bound was instead calculated by subtracting the fraction of free
nucleosomes still present. Data are presented as mean ± s.d. from three independent experiments. Source data are provided as a source data file.
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curved, distorted DNA inherent in nucleosomes. Moreover, the
LANA peptide did not disrupt this CTD:nucleosome interaction
(Supplementary Fig. 5d). Thus, the SIRT6 CTD is a unique
module among sirtuins that aids in nucleosome engagement
solely through a DNA-dependent mechanism.
The observation that SIRT6 can bind to both nucleosomal
DNA and the acidic patch suggests that the overall complex is
governed by multivalent interactions. To provide additional
support, we tested if specific complexes can form when SIRT6
(1–292) or SIRT6(1–301) is incubated with NCP(AP). Under these
conditions, without available CTD-dependent DNA interactions
and acidic patch docking, no specific binding was observed up to
1 µM (Supplementary Fig. 5e). Thus, multiple contact points are
involved in stabilizing the SIRT6:NCP complex.
The CTD promotes efficient chromatin deacetylation by
SIRT6. The tight binding imparted through the CTD may pro-
vide the full-length enzyme with a thermodynamic advantage to
interact with chromatin substrates. Thus, to determine if the
CTD-dependent binding mechanism applies to native chromatin,
we incubated SIRT6 or SIRT6(1–301) with chromatin from lysed
HCT116 cells, then subjected the cells to MNase digestion. In the
presence of full-length SIRT6, a substantial fraction of chromatin
was strictly digested into mono-nucleosomes compared to nega-
tive control, whereas SIRT6(1–301)-associated chromatin did not
exhibit an altered digestion pattern (Fig. 5a). Thus, the CTD
on full-length SIRT6 increased the nuclease sensitivity of
poly-nucleosomes, which suggests that the domain imparts SIRT6
with direct, high-affinity binding with native chromatin.
To test if enhanced binding through the CTD also promotes
more efficient histone H3K9ac deacetylation, we investigated the
ability of full-length SIRT6 or various truncated mutants to
deacetylate native nucleosomes. Our binding studies above
predict that full-length SIRT6 would be a more efficient enzyme
than a counterpart without the CTD. Indeed, when provided with
MNase-digested nucleosomes as substrate, the full-length enzyme
efficiently deacetylated endogenous H3K9ac, while SIRT6(1–292)
and SIRT6(1–301) deacetylated the modification much slower
(Fig. 5b and Supplementary Fig. 6a). Therefore, efficient
chromatin deacetylation requires the CTD-dependent nucleo-
some-binding mechanism.
To corroborate the contribution of the CTD to chromatin
binding and enzyme activity in a cellular environment, we
examined the localization of SIRT6 C-terminal deletion mutants,
as well as their ability to deacetylate chromatin (H3K9ac levels),
in cultured cells transiently overexpressing the constructs.
Because the nuclear localization motif is among the last 11
amino acids, these residues were retained in the truncated
proteins (SIRT6Δ293–344 and SIRT6Δ302–344)19. To analyze the
sub-cellular distribution of the SIRT6 constructs, we fractionated
HCT116 cells into cytoplasmic and nucleoplasmic fractions.
Compared to wild-type SIRT6, SIRT6Δ293–344 and SIRT6Δ302–344
levels were higher in both fractions (Supplementary Fig. 6b),
suggesting that truncating the CTD led to weakened chromatin
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2.5 × 10–6 5 × 10–6 1 × 10–57.5 × 10–6
[SIRT6(270–355)] (M)
Fig. 4 The C-terminal domain of SIRT6 is an intrinsically disordered DNA-binding domain. a EMSA of SIRT6 and SIRT6 C-terminal deletion mutants
bound to 601 sequence DNA reveals that full-length SIRT6 has highest affinity for DNA. All SIRT6 proteins were used at 500 nM. The image is
representative of three independent experiments. b 1H NMR spectrum of recombinant CTD (residues 270–355) shows a cluster of peaks at ~7.0–8.5 ppm.
The inset is a zoom of the spectrum at ~6.5–8.5 ppm. c EMSA of increasing concentrations of CTD bound to 50 nM DNA (top gel) and nucleosomes
(bottom gel). The data was fitted to a ligand-depleted equation and shows superimposing binding isotherms. Data are presented as mean ± s.d. from three
independent experiments. Source data are provided as a source data file.
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H3K9ac in HEK 293T cells expressing wild-type or truncated
SIRT6. Cells overexpressing the full-length enzyme showed
dramatically lowered H3K9ac levels, as predicted from our
in vitro assays and consistent with prior reports7,19 (Fig. 5b, c).
Acetylation, however, was markedly higher in cells overexpressing
the mutants (Fig. 5c). These phenotypes are consistent with the
biophysical experiments conducted above, as truncated SIRT6
retains catalytic activity, yet lacks the CTD-driven binding on
nucleosomal substrates. Thus, direct and high-affinity binding to
nucleosomes drives efficient substrate deacetylation, a character-
istic of SIRT6 unique among deacetylases.
Discussion
Multiple animal studies indicate critical cellular functions of
SIRT6 that promote longevity through regulation of metabolism
and genome maintenance3–6. SIRT6 associates with chromatin
and can dramatically decrease global levels of H3 acetylation, but
it was unclear how SIRT6 can transform bulk chromatin. Does
SIRT6 possess the inherent capacity to tightly bind nucleosomes
and perform efficient deacetylation? Here, we reveal that the
assembly of a high affinity SIRT6:nucleosome complex is func-
tionally self-contained to execute efficient H3 deacetylation.
This tight interaction is rare among chromatin-modifying
enzymes, as only the Set8 methyltransferase has a similar affinity
for nucleosomes28. Importantly, many histone deacetylases exist
in multi-subunit complexes that rely on other complex members
for nucleosome targeting18. The best characterized examples
include HDAC1 and HDAC2, which are both part of the Sin3,
NuRD, and coREST complexes, ensembles that all have additional
nucleosome-binding subunits29–35. To our knowledge, SIRT6 is
the only histone deacetylase to associate tightly with nucleosomes
through a single polypeptide. We note that this high affinity
interaction is well aligned with ascribed cellular functions.
Overpressed SIRT6 is largely observed in the chromatin fraction
of nuclei3,19,36, consistent with our own observations (Supple-
mentary Fig. 6b). As SIRT6 activity is important for cellular
homeostasis, having a pool of tight-binding enzyme would be
beneficial for prompt deacetylation of histones. Indeed, chroma-
tin occupancy of SIRT6 is enhanced during DNA damage and
disturbed by oncogenic mutations, revealing that localization
regulates function36,37. Moreover, given the highly charged nature
of SIRT6 (full-length pI= 9.5) and the presence of a long dis-
ordered domain, tight residence on chromatin may be a
mechanism to protect SIRT6 stability.
Despite reports that SIRT6 is recruited to chromatin through
interactions with NF-ΚB, Lamin A, and nucleosomes20,38,39, the
current study demonstrates that SIRT6 can engage nucleosomes
with low nanomolar affinities, which would appear sufficient to
place SIRT6 on chromatin without the need for additional
binding mechanisms. Instead, interactions with other proteins are
likely regulatory of SIRT6 activity. For instance, these proteins
might restrict or inhibit SIRT6 binding/activity, or alternatively,
shepherd SIRT6 to specific gene promoters. Furthermore, many
other proteins and peptides can also occupy the H2A/H2B acidic
patch and/or nucleosomal DNA, which might provide obstacles
for SIRT6:NCP interactions17. SIRT6 occupancy could also be
tuned by NCP or SIRT6 post-translational modifications that








































































































































Fig. 5 SIRT6 is a more efficient enzyme when bound to endogenous chromatin through the CTD. a MNase digestion of HCT116 chromatin in the
presence of SIRT6 or SIRT6(1–301) reveals that the CTD contributes to greater sensitivity of native chromatin to digestion. 10 µM SIRT6 or SIRT6(1–301) (or
buffer as negative control) was incubated with lysed HCT116 cells for 1 h before 5min of MNase treatment. Equivalent DNA content among samples was
loaded in an agarose gel. The image is representative of three independent experiments. b 100 nM SIRT6 or SIRT6(1–292) was monitored for H3K9ac
deacetylase activity on native HCT116 nucleosomes by immunoblotting. The numbers below the bands indicate the H3K9ac level relative to the no enzyme
control, all normalized to total H3 signal. c 293T cells transfected with empty FLAG tag vector, FLAG-tagged SIRT6, or the indicated FLAG-tagged mutants
were assessed for H3K9ac levels. After 48 h, the chromatin fraction was separated and blotted for H3K9ac. Deletions within the CTD result in ~2x more
acetylation. Data are presented as mean ± s.d. from three independent experiments. Source data are provided as a source data file.
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provides a simple mechanism for how a single polypeptide chain
can perform chromatin deacetylation at the global level.
Along this vein, SIRT6 engages a nucleosome core particle with
multiple regions, including a binding interface (NBR) that com-
prises the N-terminal helix and an adjacent interface, as well as
the disordered CTD (Fig. 6). In a 2:1 SIRT6:nucleosome
arrangement, both bound SIRT6 molecules likely employ the
NBR-dependent mechanism, as revealed by N-terminal antibody
competition experiments, while the CTD is exclusive for the high
affinity site only (Figs. 2d and 3d). Given the proximity of the
NBR to the CTD, we speculate that CTD-driven binding may be a
means to efficiently escort the structured core of SIRT6 to the
nucleosome. Intrinsically disordered, charged domains are a
common characteristic of chromatin-binding proteins, which use
such domains to enable fast association with target binding
partners, steering the interaction toward specific contacts with the
folded protein core40–43. Because the CTD is unique to SIRT6, as
no other nuclear sirtuin possesses such a domain similar in
sequence and charge (Supplementary Fig. 4a), we speculate that
this CTD-dependent mechanism is also a distinguishing feature
of SIRT6. We propose that the nucleosomal DNA-binding
function of the CTD allows the protein to rapidly find nucleo-
somes within nuclear confines. Further studies investigating the
on and off rates driven by the CTD in vitro and in cells would
determine if this is a plausible mechanism.
Interestingly, only a single SIRT6 molecule employs the CTD
for binding a nucleosome core particle, suggesting that the CTD
is specific for a single nucleosomal DNA region. This mechanism
would be consistent with the many nucleosome-binding proteins
that have preference for specific regions on nucleosomal DNA,
which is inherently asymmetric and features gyres of varying
curvatures17,44–46. Although the isolated CTD exhibits pro-
miscuous DNA-binding ability, the specific binding displayed
when engaging NCPs suggests that the CTD is sterically restricted
as part of the full-length SIRT6 protein, preventing non-specific
DNA binding (Fig. 1a).
The unbound CTD, consequently, may be accessible for
potential protein–protein or protein–DNA interactions. Given
the links between SIRT6 activity and DNA damage responses,
transcription, and telomere stability, the available CTD may
recruit other factors critical for these processes1. Indeed, the CTD
is required for SNF2H and CHD4 recruitment to damaged DNA
for efficient nucleosome remodeling13,14. Furthermore, as SIRT6
rapidly localizes to sites of DNA damage, the CTD may play a
role in binding damaged DNA or initiating proper cellular
responses to DNA damage. In support, a recent report reveals
that ectopic GFP-SIRT6 localizes to damaged DNA independent
of other known DNA repair proteins47. Mutagenesis of predicted
DNA-binding residues in the folded core of SIRT6 disrupted
in vitro DNA binding to a minor extent, albeit at unknown
protein concentrations and with unknown protein stability47.
Although we do not observe SIRT6:DNA binding without the
CTD at 500 nM protein concentration (Fig. 4a), there may be
multiple electrostatic contact points for DNA evident at higher
SIRT6 concentrations. The impact of relevant mutations – at the
CTD or at other putative sites – on SIRT6 recruitment to
damaged DNA would determine which site(s) are essential for
DNA damage responses. Taken together, the free CTD may be a
module that enables SIRT6 to function in concert with multiple
pathways.
On the nucleosome structure, SIRT6 molecules occupy the
acidic patches formed by H2A/H2B residues (Fig. 2a, b).
Although we do not observe differences in HDX in histone
peptides corresponding to the acidic patch residues, the lack of
coverage for H2A and the long peptide lengths seen in H2B may
preclude such changes (Supplementary Fig. 3a). Surprisingly, the
positively charged CTD does not associate with the acidic patch,
revealing that it has a strict and strong preference for DNA
(Supplementary Fig. 5d). The folded core of SIRT6, therefore,
participates in the acidic patch interaction. Because the LANA
peptide disrupts binding of both SIRT6 molecules on the NCP,
the simplest model is that the two SIRT6 molecules each occupy a
separate acidic patch on either side of the nucleosome (Fig. 6).
This mechanism is consistent with SIRT6 remaining monomeric,
and with the small surface area available on the acidic patch
(Fig. 1c)17. However, high resolution structural studies are needed
to ascertain which SIRT6 residues are directly involved, and how
the SIRT6 conformation might change. For example, recent
structural studies reveal that the Dot1L methyltransferase also
uses the acidic patch as part of a nucleosome-binding mechanism,
an interaction that restricts Dot1L to the proper orientation
needed to efficiently methylate H3K7948–51. Thus, whether the
SIRT6 conformation on nucleosomes experiences a similar
change awaits further structural analysis.
Aside from the acidic patch, we also observed destabilization








Fig. 6 Multivalent interactions comprise the SIRT6:nucleosome interaction. The nucleosome core particle is shown in surface representation and the
SIRT6 structure (residues 13–296) is in cartoon. Under the simplest model, each acidic patch on either side of the nucleosome supports binding to one
SIRT6 molecule, depicted here with purple residues representing the most protected peptides in HDX analysis (Fig. 2c). The CTD is necessary for
interactions with nucleosomal DNA at the higher affinity site.
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Fig. 3a). This H4 domain is noted to have structural plasticity: it
adopts a parallel β-sheet to interact with nucleosomal H2A, yet
rotates almost 180° to form an anti-parallel sheet with the histone
chaperone Asf116,52. Partial deletion of the H4 C-terminus leads
to a destabilized nucleosome structure, while modifications near
this domain lead to increased nucleosome unwrapping, consistent
with a site that undergoes rapid DNA breathing17,53,54. Because
the H4 C-terminal residues are buried in the nucleosome, the
simplest explanation for SIRT6-induced destabilization is that
SIRT6 interactions with histones and/or DNA perturb the
nucleosome structure. In support, recent studies show that other
proteins, including HP1 and the acidic patch-binding SNF2H,
also increase octamer plasticity at the H4 C-terminus, revealing
that even buried histone residues are susceptible to conforma-
tional changes as a result of protein-nucleosome binding23,24.
Future work is needed to determine if the SIRT6-induced H4
changes have functional consequences on chromatin structure.
The mechanisms uncovered in this work reveal how an enzyme
engages its cognate substrate, a complex structure with multiple
possible docking sites. The assembly of a high affinity SIRT6:NCP
complex allows SIRT6 to leverage the favorable free energy
changes from nucleosome binding to support thermodynamic
benefits toward deacetylation. In light of the many ongoing efforts
to develop small molecule effectors of SIRT655–57, these unique
mechanisms illuminate previously unknown roles of SIRT6
domains, and reveal that binding and activity in the context of
nucleosomes is an important consideration.
Methods
Protein and nucleosome preparation. Recombinant nucleosomes with 601-
positioning 147-bp DNA and x. laevis histones were reconstituted using the salt
gradient dialysis method, in which equimolar histone octamers and DNA were
slowly dialyzed from 2M NaCl to 10 mM NaCl58. Histones H2A, H2B, H3, and H4
were individually expressed in BL21(DE3) competent cells, then purified from
inclusion bodies under denaturing conditions by ion exchange chromatography.
To refold octamers, the histones were combined in equimolar ratios and resolved
through size exclusion chromatography. 601-positioning DNA was generated from
Eco32I digest from 32-mer inserts in a pUC19 vector (a generous gift from Peter
W. Lewis)21.
To prepare Cy3-labeled nucleosomes, Cy3 was positioned on the first nucleotide




The 601 sequence was PCR-amplified with the primers, then cleaned using
silica columns from the Qiagen PCR Purification kit. Nucleosomes were assembled
with octamers and the Cy3-labeled DNA using salt gradient dialysis. The degree of
labeling was typically >97%.
SIRT6 mutants were introduced using site-directed mutagenesis using
overlapping primers bearing the desired mutation. The mutations either
introduced alanine for the SIRT6(AAA) mutant or a stop codon to generate SIRT6
(1–292) and SIRT6(1–301). All mutants were amplified with Phusion polymerase
(Thermo Fisher) and sequence verified.
His-tagged SIRT6 and SIRT6 mutants in a pQE80 vector were overexpressed in
BL21(DE3) competent cells by induction with 0.5 mM IPTG at an OD600 of 0.8 for
18 h at 25 °C8. After harvest, the cells were sonicated and the lysate resolved by
nickel chromatography. The proteins were further purified through a Heparin
column, and finally dialyzed in 50 mM Tris, 150 mM NaCl, 0.1 mM TCEP, 5%
glycerol, and pH 7.4. The CTD (residues 270–355) was purified using the same
methods, except the CTD was dialyzed in 20 mM sodium phosphate, 100 mM
NaCl, and pH 7.3.
For fluorophore labeling on SIRT6, only two cysteines are available for
maleimide-based conjugation (cysteines 18 and 320), as the other cysteines in the
sequence are occupied with zinc coordination. To enable site-specific installation,
we mutated either C18 or C320 to serine, leaving the other available. When both
are mutated, negligible labeling was detected. For TAMRA maleimide (Anaspec)
labeling at residue 320, a C18S mutant was purified, then incubated with 10x molar
excess dye for 16 h at 4 °C. The mixture was then run through a homemade column
with G25 sephadex resin (GE Healthcare) to remove unbound dye. The absorbance
profile indicated 1:1 molar labeling. For TQ3 maleimide (AAT Bioquest) labeling,
the dye was positioned on C18, given the weaker apparent affinity observed in
EMSAs for the SIRT6(TAMRA) protein conjugated at the C-terminus, along with
subsequent observations that the C-terminus is important for binding NCPs
(Figs. 1b and 3b, c). The same procedure was followed, resulting in 80% labeling
efficiency. Pyrene (Sigma) was also labeled at C18 with 60% efficiency.
Electrophoretic mobility shift assays. For nucleosome-binding assays, 50 nM of
recombinant nucleosomes were incubated in assay buffer (10 mM Tris, 50 mM
NaCl, 0.5 mM TCEP, 6% glycerol, and pH 7.4) with varying SIRT6 concentrations
in 7 µL reactions. The reactions were performed on ice for >15 min in siliconized or
LoBind tubes (Eppendorf) to minimize protein adherence to material. The reac-
tions were then resolved in a 0.2x TBE 5% 59:1 acrylamide:bis-acrylamide gel for
90 min at 70 volts on ice. A DNA ladder (GeneRuler 1 kb Plus; Thermo Fisher) was
typically included in the gels. The gel was stained with SYBR Safe (Thermo Fisher)
and imaged on a Typhoon 9000 imager (GE Healthcare) using Typhoon Control
Software (v1.1). SYBR Safe fluorescence was excited at 473 nm and scanned with a
510 nm filter cutoff, while TAMRA was excited at 532 nm and read using a 575 nm
filter. For DNA-binding assays with 147 bp 601 sequence DNA, the same condi-
tions applied, except 100 mM NaCl was used in the buffer. To test CTD binding to
a DNA ladder, 500 nM of a 10 step ladder (Promega) was bound with varying
concentrations of protein. Each assay was repeated at least three times
independently.
The bands were quantified with ImageJ (v1.52d): fraction bound was
determined by calculating the integrated densitometry values (IDVs) of the
unbound nucleosome band (bottom) and the shifted complex(es) as the bound
fraction.
Y ¼ ðIDVBound  IDVBound BackgroundÞ  ðIDVBound  IDVBoundBackground
þ IDVFree  IDVFree BackgroundÞ;
ð1Þ
where Y is fraction bound.
To fit the isotherm, a quadratic equation was used in Prism 8 (GraphPad) to
account for ligand depletion:
Y ¼ Bmax ´ ðððKD þ Aþ XÞ  sqrtðððKD þ Aþ XÞ^2Þ  ð4 ´A ´XÞÞÞ  ð2 ´AÞÞ;
ð2Þ
where A is the concentration of nucleosomes (50 nM), Bmax is maximum binding,
and X is the varying concentrations of protein titrated into A.
In competition experiments with N- and C-terminal specific antibodies (Abcam
ab62739 and ab62738, respectively), the antibody was allowed to pre-bind SIRT6 in
the reaction buffer before nucleosomes were added. The final concentrations of the
N- and C-terminal specific antibodies were 0.04 mg/mL and 0.15 mg/mL,
respectively.
In experiments using LANA peptide (MAPPGMRLRSGRSTGAPLTRGSC;
GenScript), SIRT6 was allowed to bind nucleosomes first, followed by LANA
competition. Fraction bound was calculated according to Eq. (1) and then
converted to percent inhibition using Eq. (3). IC50 values were then calculated by
Eq. (4) from fitting in Prism 8.
Percent inhibition ¼ 100 100 ´Yð Þ; ð3Þ
where Y is fraction bound.
Percent inhibition ¼ 100 ´ I  ðIC50 þ IÞ; ð4Þ
where I is the concentration of LANA peptide.
Fluorescence spectroscopy. All FRET experiments were conducted in a Quanta
Master 400 fluorometer (Horiba) in assay buffer consisting of 50 mM Tris, 50 mM
NaCl, 0.5 mM TCEP, and pH 7.5. For each experiment, 1 nM of Cy3-labeled
nucleosomes were equilibrated in a 500-µL quartz cuvette (Starna), then titrated
with SIRT6(TQ3). Cy3 was excited at 545 nm (slit width: 5 nm) and the emission
was recorded from 560 to 700 nm (slit width: 9 nm) using FelixGX software (v4.0).
The titration was repeated four times independently.
Because TQ3 has minimal fluorescence, FRET efficiency was calculated by
measuring the decrease in donor intensity:
E ¼ 1 ðF  FiÞ; ð5Þ
where E is FRET efficiency, F is Cy3 emission when bound to a given SIRT6
concentration, and Fi is the Cy3 emission when unbound.
To calculate the Förster radius, the spectral overlap intergral, J, was computed
from the spectra of Cy3 fluorescence and TQ3 absorbance (Supplementary Fig. 2d).
Ro ¼ 0:2108 ´ ðκ2Þ ´ ðn4Þ ´Φ´ J
 ð1=6Þ
; ð6Þ
where Ro is the Förster radius, κ2 is the dipole orientation factor (2/3), n is the
refractive index of the medium (1.4), and Φ is the quantum yield of Cy3, reported
to be 0.16 on the 5′-end of duplex DNA59.
The Cy3-TQ3 distance was calculated by:
R ¼ Ro ´ ðð1 EÞ  EÞð1=6Þ; ð7Þ
where R is the distance between donor and acceptor. This leads to a calculated
distance of 36 Å. We note, however, that because C18 is located on a flexible loop
and two SIRT6(TQ3) molecules are available as acceptors on a nucleosome, this
distance is an estimate.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19018-y
10 NATURE COMMUNICATIONS |         (2020) 11:5244 | https://doi.org/10.1038/s41467-020-19018-y | www.nature.com/naturecommunications
To calculate KD(High), the titration points between 0 and 5 nM SIRT6(TQ3) were
fitted to Eq. (2) in Prism 8 to account for ligand depletion. To calculate KD(Low), the
isotherm between 5 nM to 500 nM SIRT6(TQ3) was fitted to a specific binding
equation (Eq. (8)) in Prism 8.
Y ¼ Bmax ´X  ðKDðLowÞ þ XÞ: ð8Þ
For fluorescence anisotropy experiments, 100 nM SIRT6(Py) was titrated with
unlabeled SIRT6 in 20 mM Tris, 150 mM KCl, 2 mM MgCl2, 0.5 mM TCEP, 1%
glycerol, and pH 7.5. Pyrene was excited at 347 nm (slit width: 5 nm) by light
polarized at the vertical and horizontal planes, while vertical and horizontal
emission was detected at 378 nm (slit width: 7 nm). The titration was repeated
three times independently. Anisotropy was calculated according to Eq. (9).
r ¼ ðIVV  G ´ IVHÞ  ðIVV þ 2G ´ IVHÞ; ð9Þ
where IVV and IVH is the intensity of vertically polarized light emitting at the
vertical and horizontal planes, respectively, and G is the grating factor (G= IHV/
IHH) used to correct for fluorometer sensitivity to polarization bias. The data was
fitted to Eq. (8) in Prism 8.
Hydrogen/deuterium exchange and mass spectrometry. Differential HDX-MS
experiments were conducted as follows22.
Peptide identification: peptides were identified using tandem MS (MS/MS) with
an Orbitrap mass spectrometer (Q Exactive, ThermoFisher). Product ion spectra
were acquired in data-dependent mode with the top five most abundant ions
selected for the product ion analysis per scan event. The MS/MS data files were
submitted to Mascot (v2.3.01; Matrix Science) for peptide identification. Peptides
included in the HDX analysis peptide set had a MASCOT score >20 and the MS/
MS spectra were verified by manual inspection. The MASCOT search was repeated
against a decoy (reverse) sequence and ambiguous identifications were ruled out
and not included in the HDX peptide set.
HDX-MS analysis: SIRT6 alone (5 µM), nucleosomes alone (5 µM), or the
SIRT6:nucleosome complex (5 µM) were dialyzed in 10 mM Tris, 100 mM NaCl,
0.1 mM TCEP, 5% glycerol, and pH 7.5). Five microliters of SIRT6, nucleosomes,
or the SIRT6:nucleosome complex was diluted into 20 µL D2O in exchange buffer
(50 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM MgCl2, and 2 mM DTT) and
incubated for various HDX time points (e.g., 0, 30, 60, 300, 600, 900, 1800, and
3600 s) at 4 °C and quenched by mixing with 25 µL of ice-cold 4M guanidine
hydrochloride, 1% trifluoroacetic acid. The sample tubes were immediately placed
on dry ice after the quenching reactions until the samples were injected into the
HDX platform. Upon injection, samples were passed through an immobilized
pepsin column (2 mm × 2 cm) at 200 µL/min and the digested peptides were
captured on a 2 mm × 1 cm C8 trap column (Agilent) and desalted. Peptides were
separated across a 2.1 mm × 5 cm C18 column (1.9 µm Hypersil Gold,
ThermoFisher) with a linear gradient of 4–40% CH3CN and 0.3% formic acid over
5 min. Sample handling, protein digestion, and peptide separation were conducted
at 4 °C. Mass spectrometric data were acquired using an Orbitrap mass
spectrometer with a measured resolving power of 65,000 at m/z 400. Three
biological replicates were repeated. HDX analyses were performed in duplicate or
triplicate, with single preparations of each protein:ligand complex. The intensity
weighted mean m/z centroid value of each peptide envelope was calculated and
subsequently converted into a percentage of deuterium incorporation. Corrections
for back-exchange were made on the basis of an estimated 70% deuterium
recovery, and accounting for the known 80% deuterium content of the deuterium
exchange buffer. When comparing the two samples, the perturbation %D is
determined by calculating the difference between the two samples. HDX
Workbench (v4.5) colors each peptide according to the smooth color gradient
HDX perturbation key (%D) shown in each indicated figure. Differences in %D
between −5 to 5% are considered non-significant and are colored gray according to
the HDX perturbation key60. In addition to the −5 to 5% test, unpaired t-tests are
calculated to detect statistically significant (p < 0.05) differences between samples at
each time point. At least one time point with a p value < 0.05 was present in the
data set further confirming that the difference is significant.
Nuclear magnetic resonance. NMR spectra on SIRT6(270–355) were recorded on a
Bruker Avance III spectrometer operating at 900MHz (1H) and equipped with a
triple-resonance cryogenic probe. The temperature of the sample was regulated at
25 °C during the experiment. The one-dimensional proton spectrum was recorded
using excitation sculpting for suppression of the signal from bulk water, with a
repetition delay of 1.0 s, using a spectral window of 16 ppm in the 1H dimension
and 16,384 complex points. The FID was accumulated 256 times and processed in
TopSpin for inspection.
Bioinformatics. Predictions of disorder along the SIRT6 sequence was performed
using MetaPrDOS, which uses a meta-bioinformatics approach that comprises
seven independent programs: PrDOS, DISOPRED2, DisEMBL, DISPROT(VSL2P),
DISpro, IUpred, and POODLE-S61. Theoretical pIs were calculated by the Prot-
Param tool on ExPASy62, and percent identity between residues was calculated by
ClustalW (v2.1)63.
Differential scanning fluorometry. For each experiment, 10 µM of SIRT6 or
SIRT6 mutants was equilibrated with 3.75x Sypro Orange on ice for 30 min in 20
mM potassium phosphate, pH 7.5. Fluorescence was monitored on a Bio-Rad
CFX96 real-time thermocycler during a 0.5 °C/min gradient.
HPLC deacetylation assay. To compare activity between mutants, 10 µM SIRT6
or SIRT6 mutants were incubated with 200 µM H3K9ac peptide (KQTARK(ac)
STGGKAPRWW) in 20 mM potassium phosphate, pH 7.5 at 37 °C. Catalysis was
initiated with 0.5 mM NAD+, then quenched with 2% TFA after 30 min. The
product was separated using reversed phase-HPLC on a Kinetex C18 column
(Phenomenex). The product and substrate was monitored at 214 nm during a
HPLC gradient from 33 to 100% B (30% acetonitrile, 0.05% TFA) for 25 min at 1.5
mL/min. Each assay was repeated four times.
Cell culture. The pCDNA3.1 plasmid expressing FLAG-tagged, wild-type SIRT6
was a generous gift from Raul Mostoslavsky10. HCT116 and 293T cells were grown
in 1640 RPMI (Life Technologies) supplemented with 10% FBS (Life Technolo-
gies). To introduce SIRT6Δ293–344 and SIRT6Δ302–344 mutations into the vector,
back-to-back primers were used to amplify the sequence N-terminal to residue 292
or 301 and C-terminal to 344, thereby removing the sequence in between:
SIRT6Δ293–344 Forward primer: CCCAAAAGGGTGAAGGCCAAGGCGG
SIRT6Δ293–344 Reverse primer: CGGGCGGGGCAGGGGTGG
SIRT6Δ302–344 Forward primer: CCCAAAAGGGTGAAGGCC
SIRT6Δ302–344 Reverse primer: CTCCTTGGGCTCCAGCTT
Transfection and chromatin extraction. Empty vector or pCDNA3.1 plasmids
expressing the FLAG-tagged SIRT6 or mutant proteins were transiently transfected
in 293T cells with Lipofectamine 3000 (Thermo Fisher) according to the manu-
facturer’s instructions. After 48 h, the cells were lysed with lysis buffer (10 mM
HEPES, 10 mM KCl, 0.05% NP-40, and pH 7.4) and protease inhibitors. The cells
were then centrifuged at 18,000×g to pellet the nuclei from the soluble cytoplasm.
The nuclei was then treated with low salt buffer (10 mM Tris, 0.2 mM MgCl2, 1%
Triton X-100, and pH 7.4) and centrifuged again to separate the soluble nucleo-
plasm and insoluble chromatin. The chromatin fraction was resuspended in SDS/
βME buffer for further immunoblot analysis. Gels were stained with Revert total
protein stain (LI-COR), then blotted for H3K9ac (Active Motif 39917) and FLAG
(Cell Signaling 2368). If possible, the membranes were stripped and re-blotted for
total H3 (Abcam ab46765). All primary antibodies were used at 1:5000 dilutions.
The secondary antibody used was anti-rabbit IRDye 800CW (1:7500 dilution; LI-
COR #925–32211). A protein ladder (Precision Plus; Bio-Rad) was typically
included in the gels. The fluorescent blots were visualized on an Odyssey Imager
(model #9120) using Odyssey Software (v3.0.30). The bands were quantified in
Image Studio Lite (v5.2.5; LI-COR): each H3K9ac signal was normalized to either
total H3 signal or total histone signal (around 15–20 kDa) from Revert staining.
The level of H3K9ac relative to the wild-type SIRT6 condition was reported. The
data points represent three different transfection experiments. All uncropped blots
are provided in the source data file.
HCT116 chromatin preparation and activity assays. To prepare endogenous
nucleosomes, 4 µM TSA was added to HCT116 cells 24 h before harvest to preserve
protein acetylation. The cells were harvested by trypsinization and pelleted. In all,
6.7 × 106 cells were resuspended in 1 mL digestion buffer (50 mM Tris, 1 mM
CaCl2, 0.2% Triton X-100, and pH 7.6) supplemented with protease inhibitors. For
each reaction, 75 units of MNase (Worthington) was added, and the reaction was
allowed to proceed for 5 min at 37 °C. The reaction was stopped with 5 mM EDTA
and sonicated on a Covaris ultrasonicator using two cycles of the following settings:
Peak Power - 75, Duty Factor - 5, Cycles/Burst - 100, Duration - 30 s on, 3 s off. To
assess digestion on an agarose gel, 150 µL of digested product was treated with
Proteinase K for 2 h at 55 °C. To assess the impact of SIRT6 binding on MNase
digestion, 10 µM of SIRT6 or SIRT6(1–301) was added to the cell lysate for one hour
prior to MNase treatment.
To examine H3K9ac deacetylation, 100 nM SIRT6 or SIRT6 mutants was
incubated with 0.5 mM NAD+ and native nucleosomes (25 µg total DNA content)
in 500 µL reactions on ice. For the LANA peptide competition experiment, 50 µM
peptide (or vehicle) was added to the nucleososomes for 30 min on ice. The
reactions were initiated with enzyme addition and quenched at each time point
with SDS/βME buffer. Because SIRT6(1–292) proceeded more slowly than wild-type
enzyme on peptide subtrate (Supplementary Fig. 1c; 14 nmol/min), the reactions
proceeded for 90 min to ensure ample time for deacetylation. The samples were
resolved via 4–15% gradient SDS-PAGE, stained for total protein with Revert
solution, then blotted for H3K9ac. The H3K9ac bands were normalized to either
H3 signal from the anti-H3 blot, or the total histone signal (~15–20 kDa) from
Revert staining. Each assay was repeated at least three times. All uncropped blots
are provided in the source data file.
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Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data supporting the findings of this study are available from the corresponding author
upon reasonable request. HDX data are available in Figshare [https://doi.org/10.6084/m9.
figshare.12937103.v1]. Figures of nucleosomes and SIRT6 were generated from publicly
available datasets from the Protein Data Bank (nucleosome: 3LZ0 [https://doi.org/
10.2210/pdb3lz0/pdb]; SIRT6: 3PKJ [https://doi.org/10.2210/pdb3pkj/pdb]). Source data
are provided with this paper.
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